Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review

Title
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
Authors
Keywords
Melanoma, Brain metastases, Vemurafenib, Dabrafenib, Ipilimumab, Survival
Journal
CANCER TREATMENT REVIEWS
Volume 45, Issue -, Pages 38-45
Publisher
Elsevier BV
Online
2016-03-09
DOI
10.1016/j.ctrv.2016.03.003

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started